Oftalmología

Certificada por el Consejo Mexicano de Oftalmología No. 3746

​

Miembro de la Sociedad Mexicana de Oftalmología No. 4218

​

Miembro del Colegio de Oftalmólogos de Jalisco

​

Certificación en Buenas Prácticas Clínicas (GCP - Good Clinical Practice)

​

​Múltiples publicaciones científicas en revistas internacionales: 

​

• Sánchez-Ríos, A, Correa-Gallegos, EY, Medina-Espinoza, JM, et al. Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate. Anim Models Exp Med. 2022; 5: 266– 273. doi:10.1002/ame2.12218

• Muñoz-Villegas P, Sanchez-Rios A, Quinonez-Alvarado MG, Olvera-Montaño O, Quintana-Hau JD, Baiza-Duran L. Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab. J Exp Pharmacol. 2021;13:545-554. Published 2021 May 31. doi:10.2147/JEP.S308388

• Baiza-Durán, L., Sánchez-Ríos, A., González-Barón, J. et al. Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits. Int J Retin Vitr 6, 32 (2020). https://doi.org/10.1186/s40942-020-00235-y

• Sanchez-Rios, A; Muñoz Villegas, PC; Olvera-Montaño, O; Baiza-Durán, LM. Safety and tolerability evaluation in New Zealand white rabbits after repeated intravitreal injections of an anti-VEGF-A monoclonal antibody vs. ranibizumab. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3291. https://iovs.arvojournals.org/article.aspx?articleid=2769105

• Sanchez-Castellanos ,VE; Paczka, JA; Gomez-Aguayo, F; Gil-Carrasco, F; Hartleben, C; Baiza-Durán, LM; Olvera-Montaño, O; Sanchez-Rios, A;  Muñoz Villegas, PC (2018) A phase III, randomized, clinical, crossover study to evaluate the non-inferiority of an ophthalmic solution of preservative-free latanoprost at 0.005% in patients with primary open-angle glaucoma. New Front Ophthalmol. 4: DOI: 10.15761/NFO.1000202 https://www.oatext.com/pdf/NFO-4-202.pdf

​

​